LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

Начало・Списък с акции・Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings Inc (Class A)

Затворен

СекторЗдравеопазване

3.14 1.95

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

3.16

Ключови измерители
By Trading Economics
Приходи	-15M -40M
Продажби	8.2M 50M
Марж на печалбата	-80.43
Служители	435
EBITDA	-19M -42M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+29.87% upside

Дивиденти
By Dow Jones
Следващи печалби	11.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	214M 1.3B
Предишно отваряне	1.19
Предишно затваряне	3.14

Настроения в новините

By Acuity

50%

133 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

2.02 / 2.115 Подкрепа & съпротива

Maravai LifeSciences Holdings Inc (Class A) Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.03.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15.03.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16.03.2026 г., 00:00 ч. UTC

Значими събития в новините

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15.03.2026 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15.03.2026 г., 23:44 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15.03.2026 г., 23:35 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15.03.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15.03.2026 г., 22:37 ч. UTC

Пазарно говорене

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15.03.2026 г., 22:18 ч. UTC

Пазарно говорене

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15.03.2026 г., 22:00 ч. UTC

Значими събития в новините

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15.03.2026 г., 22:00 ч. UTC

Значими събития в новините

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15.03.2026 г., 03:00 ч. UTC

Значими събития в новините

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14.03.2026 г., 15:00 ч. UTC

Значими събития в новините

Iran War Delivers Windfall to America's Oil Country -- WSJ

14.03.2026 г., 02:03 ч. UTC

Печалби

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14.03.2026 г., 01:32 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14.03.2026 г., 00:29 ч. UTC

Придобивния, сливания и поглъщания

13D Filings -- Barrons.com

13.03.2026 г., 22:27 ч. UTC

Пазарно говорене

Значими събития в новините

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13.03.2026 г., 22:13 ч. UTC

Пазарно говорене

Значими събития в новините

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13.03.2026 г., 22:04 ч. UTC

Пазарно говорене

Значими събития в новините

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13.03.2026 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

13.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Значими събития в новините

Financial Services Roundup: Market Talk

13.03.2026 г., 20:02 ч. UTC

Пазарно говорене

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13.03.2026 г., 19:50 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13.03.2026 г., 19:35 ч. UTC

Значими събития в новините

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Maravai LifeSciences Holdings Inc (Class A) Прогноза

Ценова цел

By TipRanks

29.87% нагоре

12-месечна прогноза

Среден 4 USD 29.87%

Висок 5 USD

Нисък 3 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Maravai LifeSciences Holdings Inc (Class A) през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Maravai LifeSciences Holdings Inc (Class A) през последните 3 месеца.

Техническа оценка

By Trading Central

2.02 / 2.115Подкрепа & съпротива

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Настроение

By Acuity

133 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.